Pryce G - Search Results

1

Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis.

Licht-Mayer S, Campbell GR, Mehta AR, McGill K, Symonds A, Al-Azki S, Pryce G, Zandee S, Zhao C, Kipp M, Smith KJ, Baker D, Altmann D, Anderton SM, Kap YS, Laman JD, 't Hart BA, Rodriguez M, Franklin RJM, Chandran S, Lassmann H, Trapp BD, Mahad DJ. Licht-Mayer S, et al. Among authors: pryce g. Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12851. doi: 10.1111/nan.12851. Epub 2022 Oct 7. Neuropathol Appl Neurobiol. 2023. PMID: 36181265 Free PMC article.

2

Cannabinoids control spasticity and tremor in a multiple sclerosis model.

Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L. Baker D, et al. Among authors: pryce g. Nature. 2000 Mar 2;404(6773):84-7. doi: 10.1038/35003583. Nature. 2000. PMID: 10716447

3

Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis rat.

Ahmed Z, Gveric D, Pryce G, Baker D, Leonard JP, Cuzner ML, Diemel LT. Ahmed Z, et al. Among authors: pryce g. Am J Pathol. 2001 Jun;158(6):2127-38. doi: 10.1016/s0002-9440(10)64684-6. Am J Pathol. 2001. PMID: 11395390 Free PMC article.

4

A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis : inflammation versus degeneration.

Ahmed Z, Doward AI, Pryce G, Taylor DL, Pocock JM, Leonard JP, Baker D, Cuzner ML. Ahmed Z, et al. Among authors: pryce g. Am J Pathol. 2002 Nov;161(5):1577-86. doi: 10.1016/S0002-9440(10)64436-7. Am J Pathol. 2002. PMID: 12414506 Free PMC article.

5

The therapeutic potential of cannabis in multiple sclerosis.

Baker D, Pryce G. Baker D, et al. Among authors: pryce g. Expert Opin Investig Drugs. 2003 Apr;12(4):561-7. doi: 10.1517/13543784.12.4.561. Expert Opin Investig Drugs. 2003. PMID: 12665412 Review.

6

Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice.

Pryce G, Giovannoni G, Baker D. Pryce G, et al. Neurosci Lett. 2003 May 1;341(2):164-6. doi: 10.1016/s0304-3940(03)00159-9. Neurosci Lett. 2003. PMID: 12686391

7

Quantification of neurodegeneration by measurement of brain-specific proteins.

Petzold A, Baker D, Pryce G, Keir G, Thompson EJ, Giovannoni G. Petzold A, et al. Among authors: pryce g. J Neuroimmunol. 2003 May;138(1-2):45-8. doi: 10.1016/s0165-5728(03)00092-4. J Neuroimmunol. 2003. PMID: 12742652 Free article.

8

The therapeutic potential of cannabis.

Baker D, Pryce G, Giovannoni G, Thompson AJ. Baker D, et al. Among authors: pryce g. Lancet Neurol. 2003 May;2(5):291-8. doi: 10.1016/s1474-4422(03)00381-8. Lancet Neurol. 2003. PMID: 12849183 Review.

9

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.

Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, Ledent C, Petzold A, Thompson AJ, Giovannoni G, Cuzner ML, Baker D. Pryce G, et al. Brain. 2003 Oct;126(Pt 10):2191-202. doi: 10.1093/brain/awg224. Epub 2003 Jul 22. Brain. 2003. PMID: 12876144

10

Emerging properties of cannabinoid medicines in management of multiple sclerosis.

Pryce G, Baker D. Pryce G, et al. Trends Neurosci. 2005 May;28(5):272-6. doi: 10.1016/j.tins.2005.03.006. Trends Neurosci. 2005. PMID: 15866202 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters